RZLT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Rezolute Inc

NASDAQ | RZLT

9.01

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$850.31M

Market Cap

-

P/E Ratio

-0.94

EPS

$11.46

52 Week High

$2.21

52 Week Low

HEALTHCARE

Sector

RZLT Chart

Recent Chart
Price Action

RZLT Technicals

Tags:

RZLT Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$80M
Selling General And Administrative $18M
Research And Development $62M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $31K
Income Before Tax -$74M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$74M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$80M
Net Income -$74M

Revenue & Profitability

Earnings Performance

RZLT Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $175M
Total Current Assets $171M
Cash And Cash Equivalents At Carrying Value $94M
Cash And Short Term Investments $94M
Inventory -
Current Net Receivables $700K
Total Non Current Assets $4.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $74M
Other Current Assets $3.3M
Other Non Current Assets -
Total Liabilities $13M
Total Current Liabilities $12M
Current Accounts Payable $5.8M
Deferred Revenue -
Current Debt -
Short Term Debt $632K
Total Non Current Liabilities $1.5M
Capital Lease Obligations $1.6M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.6M
Other Current Liabilities $5.5M
Other Non Current Liabilities -
Total Shareholder Equity $162M
Treasury Stock -
Retained Earnings -$404M
Common Stock $87K
Common Stock Shares Outstanding $76M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$69M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $31K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$15M
Cashflow From Financing $107M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$74M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$80M
Selling General And Administrative $18M
Research And Development $62M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $31K
Income Before Tax -$74M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$74M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$80M
Net Income -$74M

RZLT News

RZLT Profile

Rezolute Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Rezolute, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, dedicated to developing innovative therapies for rare and metabolic diseases. The company boasts a promising pipeline targeting significant unmet medical needs, underpinned by its commitment to scientific advancement and clinical excellence. Through strategic collaborations and a focus on improving patient outcomes, Rezolute is uniquely positioned to make a substantial impact in the biopharmaceutical sector, aiming to transform the treatment landscape for underserved patient populations.

LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
NVDA
+0.85%
$181.46
VHAI
0.00%
$0.00
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
TWOH
0.00%
$0.00
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
AAL
+2.00%
$14.24
ASST
-1.42%
$1.03
BMNR
+10.26%
$31.91
F
-1.51%
$12.96
AAPL
+1.09%
$286.19
ADAP
-15.14%
$0.05
WBD
+2.76%
$24.53
MARA
+3.38%
$11.91
BAC
-0.09%
$53.19
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
BMNU
+19.54%
$7.34
AMD
-2.05%
$215.24
CAN
+2.04%
$0.96
YGMZ
-21.06%
$0.08
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
MRVL
+1.96%
$92.89
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
ITUB
+2.64%
$7.89
CIFR
-10.41%
$17.64
GOOGL
+0.29%
$315.81
PLTR
+1.91%
$170.69
SRM
+53.27%
$10.30
GRAB
-0.18%
$5.26
APLD
-0.56%
$28.05
EXK
-1.70%
$9.24
INHD
-15.40%
$0.14
BQ
+41.53%
$2.76
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
VALE
+1.57%
$12.89
EB
+78.62%
$4.43
RGTI
+1.83%
$23.88
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
ASBP
+1.11%
$0.09
MTSR
-0.35%
$70.50
RIG
-0.91%
$4.31
NFLX
+0.20%
$109.35
PCG
-3.28%
$15.32
CRWV
-1.33%
$76.03
HOOD
+2.19%
$125.95
IXHL
+12.12%
$0.39
GOOG
+0.28%
$316.02
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
VICI
-0.48%
$28.45
AFMD
-34.94%
$0.18
VZ
-0.31%
$40.61
TMC
+17.74%
$7.40
BA
+10.14%
$205.38
AG
+2.51%
$15.91
AVGO
-1.16%
$381.57
RIOT
-1.67%
$15.22
STLA
+2.81%
$10.95
VCIG
+0.95%
$1.06
NOK
+1.14%
$6.19
LUMN
+10.25%
$9.14
QBTS
+5.04%
$22.50
TAOP
+32.71%
$2.84
AMCR
-1.63%
$8.40
ORCL
+0.07%
$201.10
MSFT
+0.66%
$490.00
CGC
-1.76%
$1.11
SMCI
-1.46%
$32.92
SMR
+4.59%
$18.91
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
UBER
+1.15%
$87.57
EOSE
-6.06%
$12.78
MODV
-25.22%
$0.43
TSLG
-0.64%
$9.21
CCL
-0.34%
$25.84
IQ
-3.34%
$2.02
ALAB
-13.46%
$142.94
RXRX
-0.91%
$4.32
JOBY
+2.67%
$13.83
AMC
-2.12%
$2.30
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
CRDO
+10.11%
$188.44
HPE
-0.09%
$21.92
XPEV
-7.91%
$19.66
LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
NVDA
+0.85%
$181.46
VHAI
0.00%
$0.00
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
TWOH
0.00%
$0.00
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
AAL
+2.00%
$14.24
ASST
-1.42%
$1.03
BMNR
+10.26%
$31.91
F
-1.51%
$12.96
AAPL
+1.09%
$286.19
ADAP
-15.14%
$0.05
WBD
+2.76%
$24.53
MARA
+3.38%
$11.91
BAC
-0.09%
$53.19
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
BMNU
+19.54%
$7.34
AMD
-2.05%
$215.24
CAN
+2.04%
$0.96
YGMZ
-21.06%
$0.08
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
MRVL
+1.96%
$92.89
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
ITUB
+2.64%
$7.89
CIFR
-10.41%
$17.64
GOOGL
+0.29%
$315.81
PLTR
+1.91%
$170.69
SRM
+53.27%
$10.30
GRAB
-0.18%
$5.26
APLD
-0.56%
$28.05
EXK
-1.70%
$9.24
INHD
-15.40%
$0.14
BQ
+41.53%
$2.76
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
VALE
+1.57%
$12.89
EB
+78.62%
$4.43
RGTI
+1.83%
$23.88
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
ASBP
+1.11%
$0.09
MTSR
-0.35%
$70.50
RIG
-0.91%
$4.31
NFLX
+0.20%
$109.35
PCG
-3.28%
$15.32
CRWV
-1.33%
$76.03
HOOD
+2.19%
$125.95
IXHL
+12.12%
$0.39
GOOG
+0.28%
$316.02
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
VICI
-0.48%
$28.45
AFMD
-34.94%
$0.18
VZ
-0.31%
$40.61
TMC
+17.74%
$7.40
BA
+10.14%
$205.38
AG
+2.51%
$15.91
AVGO
-1.16%
$381.57
RIOT
-1.67%
$15.22
STLA
+2.81%
$10.95
VCIG
+0.95%
$1.06
NOK
+1.14%
$6.19
LUMN
+10.25%
$9.14
QBTS
+5.04%
$22.50
TAOP
+32.71%
$2.84
AMCR
-1.63%
$8.40
ORCL
+0.07%
$201.10
MSFT
+0.66%
$490.00
CGC
-1.76%
$1.11
SMCI
-1.46%
$32.92
SMR
+4.59%
$18.91
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
UBER
+1.15%
$87.57
EOSE
-6.06%
$12.78
MODV
-25.22%
$0.43
TSLG
-0.64%
$9.21
CCL
-0.34%
$25.84
IQ
-3.34%
$2.02
ALAB
-13.46%
$142.94
RXRX
-0.91%
$4.32
JOBY
+2.67%
$13.83
AMC
-2.12%
$2.30
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
CRDO
+10.11%
$188.44
HPE
-0.09%
$21.92
XPEV
-7.91%
$19.66
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.